A61P 15 - Drugs for genital or sexual disorders; Contraceptives

Patents for A61P 15 - Drugs for genital or sexual disorders; Contraceptives (55,635)
12/2004
12/23/2004	US20040259890 trans-3'-oxo-N-(trans-4-phenylcyclohexyl)-spiro[cyclohexane-1,1'(3'H)-isobenzofuran]-4-carboxamide e.g.; neuropeptide Y receptor antagonists for treatment of bulimia, obesity or diabetes for example
12/23/2004	US20040259879 Antiarthritic agents; colon cancer, neurodegenerative agents
12/23/2004	US20040259871 Carbonylbenzoxazine compounds for enhancing glutamatergic synaptic responses
12/23/2004	US20040259849 17Alpha-hydroxy-14Beta-steroids with hormonal effect
12/23/2004	US20040259840 Using phosphoglycerides, lipid having sphingosine base, glycerides and sterol; wound healing agents; atherosclerosis
12/23/2004	US20040259817 Methods and formulations for the treatment of female sexual dysfunction
12/23/2004	US20040259788 Use of neurotoxin therapy for treatment of urologic and related disorders
12/23/2004	US20040259192 into two fragments, using the human matrix metalloproteinase MMP-3; administering 3-(3-mercaptopropyl)-1-methyl-(1H,3H)quinazoline-2,4-dione and/or 3-(2'-mercaptoethylamino)-2H-1,2,4-benzothiadiazine-1,1-dioxide to treat tumors or diabetic retinopathy; also wound healing, cardiac infarction treatment
12/23/2004	US20040258689 Augmenting activin induced signaling in cells; screening for complex inhibitors; treatment of reproductive, developmental, skin, bone, hepatic, hematopoietic and/or central nervous system disorders; prostrate cancer
12/23/2004	CA2849228A1 Process for the manufacture of stable shaped particles consisting of estradiol and cholesterol
12/22/2004	EP1488803A1 Neurotoxic component of botulinum toxins for treating neuromuscular disorders
12/22/2004	EP1488799A2 Soluble lymphotosin-Beta receptors and anti-lymphotoxin receptor and ligand antibodies as therapeutic agents for the treatment of immunological disease
12/22/2004	EP1488794A2 Methods of contraception
12/22/2004	EP1488784A1 Male contraceptive implant
12/22/2004	EP1487992A2 Central airway administration for systemic delivery of therapeutics
12/22/2004	EP1487870A2 Cell-permeable peptide inhibitors of the jnk signal transduction pathway
12/22/2004	EP1487843A2 Substituted phenylacetic acids
12/22/2004	EP1487830A1 Novel crystalline form of 5-(4-((3-methyl-4-oxo-3,4-dihydroquinazolin-2-yl)methoxy)benzyl)thiazolidine-2,4-dione potassium salt
12/22/2004	EP1487823A1 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with cdk inhibitory activity
12/22/2004	EP1487804A2 Aminoindazole derivatives as protein-kinase inhibitors
12/22/2004	EP1487793A1 Piperidine derivatives useful as modulators of chemokine receptor activity
12/22/2004	EP1487783A2 Irreversible selective androgen receptor modulators and methods of use thereof
12/22/2004	EP1487778A1 Substituted 4-aminocyclohexanols
12/22/2004	EP1487774A2 Bipolar trans carotenoid salts and their uses
12/22/2004	EP1487489A2 METHODS OF PREVENTING OR TREATING DISORDERS BY ADMINISTERING AN INTEGRIN avb3 ANTAGONIST IN COMBINATION WITH AN HMG-CoA REDUCTASE INHIBITOR OR A BISPHOSPHONATE
12/22/2004	EP1487479A2 Mutant glycoproteins
12/22/2004	EP1487458A2 Multi-substitued selective androgen receptor modulators and methods of use thereof
12/22/2004	EP1487449A1 Tyrosyl derivatives and their use as p2x7 receptor modulators
12/22/2004	EP1487442A1 Thiazolidine carboxamide derivatives as modulators of the prostaglandin f receptor
12/22/2004	EP1487432A2 Suramin and derivatives thereof as topical microbicide and contraceptive
12/22/2004	EP1333719A4 Corticotropin releasing factor receptor 2 deficient mice and uses thereof
12/22/2004	EP1189907B1 Thienopyrimidines as phosphodiesterase inhibitors
12/22/2004	CN1556852A Lactic acid producing bacteria for use as probiotic organisms in the human vagina
12/22/2004	CN1555862A Chinese medicine for treating palvic infection
12/22/2004	CN1555816A Medicne for treating proliferation of mammary gland and its preparing process
12/22/2004	CN1181075C Pyrimidine-4-keto compound, its preparation method and medicine composition containing them
12/22/2004	CN1181064C Process for preparing crystallization formed N-(4-trifluoromethylphenyl)-5-methyl isooxazo-4-carboxamide
12/22/2004	CN1181050C Noval substituted dimeric compounds, its preparing process and medicinal composition containing same
12/22/2004	CN1180835C Medicinef or treating dysmenorrhea and its preparing method
12/22/2004	CN1180824C Chinese medicine for treating male sexual disfunction and preparing process thereof
12/22/2004	CN1180818C Capsule for treatnig gynae cological disease and its prepn. process
12/22/2004	CN1180801C Magnetotherapeutic medicinal pad and its preparing process
12/21/2004	US6833444 An erythromycin-type antibiotic based on a perhydro-oxazolo(5,4-c)oxacyclotetradecine ring; bactericides; antiprotazoa agents; non-polyene and ansa macrolide antibiotics
12/21/2004	US6833378 Pyridines, pyrimidines, purinones, pyrrolopyrimidinones and pyrrolopyridinones; useful in the treatment disorders including CNS and stress-related disorders.
12/21/2004	US6833372 A hormone inhibitors of gonadotropin releasing hormone, an antigonadotropins, new drug compound contains a furanyl 2-carboxylic acid -(2,4-dimethoxy-pyrimidin-5-yl)-amide groups
12/21/2004	US6833364 Inhibiting degradation of cyclic guanosine monophosphate; cardiovascular disorders; such as 3-(4-amino-5-cyclopropyl-pyrimidin-2-yl)-1-(2-fluorobenzyl)1H-pyrazolo-(3,4 -b)-pyridine
12/21/2004	CA2317604C Matrix metalloprotease inhibitors
12/16/2004	WO2004108726A1 2-SUBSTITUTED PHENYL-5,7-DIALKYL-3,7-DIHYDROPYRROLE [2,3-d] PYRIMIDINE-4-ONE DERIVATIVES, THE PREPARATION AND THE PHARMACEUTICAL USE THEREOF
12/16/2004	WO2004108138A1 Therapeutic combinations comprising pde inhibitors and vasopressin receptor antagonists for the treatment of dysmenorrhoea
12/16/2004	US20040254382 Imidazolyl derivatives as corticotropin releasing factor inhibitors
12/16/2004	US20040254378 2-Methanesulfone group; Side effect reduction; Nonsteroidal Antiinflammatory
12/16/2004	US20040254362 Nucleotide sequences coding polypeptide associate with fatty acid metabolism for use in diagnosis, prevention and treatment of obesity, diabetes and heart disease
12/16/2004	US20040254338 Melanin-concentrating hormone antagonists
12/16/2004	US20040254233 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors
12/16/2004	US20040254189 Jnk inhibitors
12/16/2004	US20040254185 Endothelial growth factor antagonist; angiogenesis inhibitor; skin disorders; anticancer agents; endometriosis; Crohn's disease; leukemia; antiarthritic agents; vision defects
12/16/2004	US20040254132 Ovary-specific genes and proteins
12/16/2004	US20040254093 Antiinflammatory agents; cardiovascular disorders; anticancer agents; antidiabetic agents
12/16/2004	US20040253709 Schistosoma protein for use in treatment of organ-specific autoimmune diseases
12/16/2004	US20040253685 eNOS mutations useful for gene therapy and therapeutic screening
12/16/2004	US20040253588 Cytochrome p450 monooxygenase for use in identifying modulators for treatment, diagnosis and prevention of autoimmune/inflammatory, cell proliferative, developmental, endocrine, eye, metabolic, gastrointestinal and liver disorders
12/16/2004	US20040253245 Modulating an immune response by administering a modulator of Notch intracellular domain protease activity, including modulators of presenilin and presenilin-dependent gamma secretase activity; immunotherapy; treatment of Alzheimer's disease
12/16/2004	US20040253217 Lactic acid producing bacteria for use as probiotic organisms in the human vagina
12/16/2004	CA2528975A1 Therapeutic combinations comprising pde inhibitors and vasopressin receptor antagonists for the treatment of dysmenorrhoea
12/15/2004	EP1486497A1 Novel pyridone derivative
12/15/2004	EP1486214A1 Botulinum toxins for treating muscle spasm
12/15/2004	EP1485388A2 Topiramate salts and compositions comprising and methods of making and using the same
12/15/2004	EP1485384A1 Pyrazolo(1,5-a)pyridine derivatives as neurotransmitter modulators
12/15/2004	EP1485370A1 Amino-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485364A1 Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485360A2 Sodium channel blockers
12/15/2004	EP1485359A2 Sodium channel blockers
12/15/2004	EP1485356A1 NON-PEPTIDE GnRH ANTAGONISTS
12/15/2004	EP1485354A1 Sulfonylamino-derivatives as novel inhibitors of histone deacetylase
12/15/2004	EP1485353A1 New inhibitors of histone deacetylase
12/15/2004	EP1485160A1 Intraductal management of breast lesions involving therapeutic or diagnostic agents
12/15/2004	EP1485103A1 Sulfatase inhibiting continuous progestogen contraceptive regimens
12/15/2004	EP1485099A1 Inhibitors of histone deacetylase
12/15/2004	EP1485095A1 Fluorinated 4-azasteroid derivatives as androgen receptor modulators
12/15/2004	EP1485089A1 Combination treatments for chemokine-mediated diseases
12/15/2004	EP1485088A1 Opioid receptor active 4-(3-hydroxyphenyl) or 4-(3-alkoxyphenyl)-1,2,4-triazole compounds
12/15/2004	EP1485085A1 Phosphate prodrugs of fluorooxindoles
12/15/2004	EP1485078A1 Ne and 5-ht reuptake inhibitors for treating visceral pain syndromes
12/15/2004	EP1485072A1 Hormone-containing transdermal therapeutic system with an active substance reservoir based on vinylacetate-vinylpyrrolidone copolymer with improved cohesion.
12/15/2004	EP1406496A4 Method and composition for enhancing sexual desire
12/15/2004	EP1383515B1 Activation of natural killer cells by adenosine a3 receptor agonists
12/15/2004	EP1307447B1 3-indolyl-4-phenyl-1h-pyrrole-2,5-dione derivatives as inhibitors of glycogen synthase kinase-3beta
12/15/2004	EP1226160B1 Novel antiarrhythmic peptides
12/15/2004	EP1119543B1 N-aralkylaminotetralins as ligands for the neuropeptide y y5 receptor
12/15/2004	CN1555374A Novel pyridine-substituted pyrazolopyridine derivatives
12/15/2004	CN1555266A Hormone replacement therapy
12/15/2004	CN1555264A Formulations for treatment of mucosal associated conditions with an immune response modifier
12/15/2004	CN1554440A Medicinal composition for treating synecopathy
12/15/2004	CN1179970C Purine derivatives
12/15/2004	CN1179969C European verbena herb extract, and preparing process and use thereof
12/15/2004	CN1179961C Sulfonamides for treatment of endothelin-mediated disorders
12/15/2004	CN1179753C Contraceptive compositions containing antiprogesting and progestinic
12/15/2004	CN1179750C Recombination alpha-interferon gelatin injection
12/15/2004	CN1179738C Medicine for controlling sex of calf
12/15/2004	CN1179733C Pill for nourishing yin and tonifying kidney

1 ... 294 295 296 297 298 299 300 301 302 303 304 305 306 307 308 309 310 311 312 313 314 ... 557